Global /South Korea /Healthcare /Medical Devices /302550

Remed Co.,Ltd.

302550

• KRX: 302550 • Delayed

3,090KRW 0%

2.05 USD

As of 18 June 2026, Remed Co.,Ltd. has a market cap of $62.61M USD, ranking #28903 globally and #1570 in South Korea. It ranks #2626 in the Healthcare sector, and #540 in the Medical Devices industry.

Global Rank

28903

Country Rank

1570

Sector Rank

2626

Industry Rank

540

Key Stats

Market Cap

$62.61MUSD

95.5B KRW

Enterprise Value

$59.55MUSD

89.89B KRW

Revenue (TTM)

$16.07MUSD

24.5B KRW

EBITDA (TTM)

$1.42MUSD

2.14B KRW

Net Income (TTM)

$344.97KUSD

526.2M KRW

EBITDA Margin

8.7%

Profit Margin

2.1%

PE Ratio

181.5

PS Ratio

3.9

PB Ratio

2.3

EV/EBITDA

42.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Geun-Yong Lee open_in_new

Employees

Founded

2003

Website

remed.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-0.6%	-0.8%	4.6%	-7.8%	0.7%	-4.6%	23%	-42%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	302550 (주)리메드 Ordinary Shares ISIN: KR7302550009 Shares Out.: Shares Outstanding: 30.518M¹ Shares Float: 18.846M² TV: TradingView: KRX: 302550 SA: Stock Analysis: KRX: 302550 YF: Yahoo Finance: 302550.KS GF: Google Finance: KRX: 302550 BA: Barron's: 302550 MS: Morningstar: XKRX: 302550	3,090 KRW	TV: TradingView: KRX: 302550 SA: Stock Analysis: KRX: 302550 YF: Yahoo Finance: 302550.KS GF: Google Finance: KRX: 302550 BA: Barron's: 302550 MS: Morningstar: XKRX: 302550

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Remed Co.,Ltd.

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides extracorporeal shock wave therapy; and technology to activate the sensory function of prostate and strengthen the pelvic floor muscle by stimulating them with electromagnetic pulse. The company was formerly known as CR Technology Co., Ltd. and changed its name to Remed Co., Ltd. in 2013. Remed Co., Ltd. was founded in 2003 and is headquartered in Daejeon, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.46B 3.75T KRW 4K%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.22B 1.86T KRW 2K%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.19B 1.81T KRW 2K%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.14B 1.74T KRW 2K%	-	South Korea
Seegene, Inc. KRX: 096530	$757.33M 1.16T KRW 1K%	23.9	South Korea
i3system Inc. KRX: 214430	$530.8M 809.64B KRW 748%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 277K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 257K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 254K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 202K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 193K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 163K%	22.2	Ireland

chevron_leftBack